Antimicrobial agents

Drug-Biomembrane Interaction Studies: The Application of Calorimetric Techniques

Volumn , Issue , 2013, Pages 305-333

  Musumeci, Teresa ^a   Puglisi, Giovanni ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Antibiotic; Antifungal; Antimicrobial peptide agents; Antiviral; DiPoPe; DMPC; DMPG; Lipid composition; LUV; Membrane curvature strain; MLV

Indexed keywords

EID: 84903406641     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781908818348.305     Document Type: Chapter

References (38)

1. Andriole T.V. Current and future antifungal therapy: new targets for antifungal therapy. Int. J. Antimicrob. Agents 2000, 16:317-321.
2. Aranda F.J., Teruel J.A., Ortiz A. Interaction of synthetic peptide corresponding to the N-terminus of canine distemper virus fusion protein with phospholipid vesicles: a biophysical study. Biochim. Biophys. Acta 2003, 1618:51-58.
3. Fresta M., Puglisi G. Phospholipid vesicles as biosensors to evaluate antimicrobial agent-membrane interaction. Rec. Res. Devel. Antimicrob. Agents Chemother 2000, 4:27-53.
4. Epand R.M., Epand R.F. Bacterial membrane lipids in the action of antimicrobial agents. J. Pept. Sci 2010, 17:298-305.
5. Fresta M., Furneri M.P., Mezzasalma E., Nicolosi V.M., Puglisi G. Correlation of trimethoprim and brodimoprim physicochemical and lipid membrane interaction properties with their accumulation in human neutrophils. Antimicrob. Agents Chemother 1996, 40:2865-2873.
6. Fresta M., Ricci M., Rossi C., Furneri P.M., Puglisi G. Antimicrobial nonapeptide leucinostatin A-dependent effects on the physical properties of phospholipid model membranes. J. Coll. Interface Sci 2000, 226:222-230.
7. Fresta M., Guccione S., Beccari A.R., Furneri P.M., Puglisi G. Combining molecular modeling with experimental methodologies: mechanism of membrane permeation and accumulation of ofloxacin. Bioorg. Med. Chem 2002, 10:3871-3889.
8. Oszlánczi A., Bota A., Czabai G., Klumpp E. Structural and calorimetrical studies of the effect of different aminoglycosides on DPPC liposomes. Coll. Surf. B Biointerfaces 2009, 69:116-121.
9. Oszlánczi A., Bota A., Klumpp E. Influence of aminoglycoside antibiotics on the thermal behavior and structural features of DPPE-DPPG model membranes. Coll. Surf. B Biointerfaces 2010, 75:141-148.
10. Oszlánczi A., Bota A., Klumpp E. Layer formation in the bacteria membrane mimetic DPPE-DPPG/water system induced by sulfadiazine. Biophys. Chem 2007, 125:334-340.
11. Lohner K., Latal A., Degovics G., Gariedel P. Packing characteristics of model system mimicking cytoplasmic bacterial membranes. Chem. Phys. Lipids 2001, 111:177-192.
12. Oszlánczi A., Bota A., Czabai G., Berenyi S., Klumpp E. Structural and morphological changes in bacteria-membrane mimetic DPPE/DPPG/water systems induced by sulfadiazine. Coll. Surf. B Biointerfaces 2010, 76:519-528.
13. Lohner K., Prenner E.J. Differential scanning calorimetry and X-ray diffraction studies of the specificity of the interaction of antimicrobial peptides with biomembrane-mimetic systems. Biochim. Biophys. Acta 1999, 1462:141-156.
14. Haney E.F., Nathoo S., Vogel H.J., Prenner E.J. Induction of non-lamellar lipid phase by antimicrobial peptides: a potential link to mode of action. Chem. Phys. Lipids 2010, 163:82-93.
15. Zimmerberg J., Kozlov M.M. How proteins produce cellular membrane curvature. Nat. Rev. Mol. Cell. Biol 2006, 7:9-19.
16. Matsuzaki K., Sugishita K., Ishibe N., Ueha M., Nakata S., et al. Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry 1998, 37:11856-11863.
17. Hallock K.J., Lee D.K., Ramamoorthy A. MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain. Biophy. J 2003, 84:3052-3060.
18. Galanth C., Abbassi F., Lequin O., Ayala-Sanmartin J., Ladram A., et al. Mechanism of antibacterial action of dermaseptin B2: interplay between helix-hinge-helix structure and membrane curvature strain. Biochemistry 2009, 48:313-327.
19. Nomura K., Corzo G. The effect of binding of spider-derived antimicrobial peptides, oxyopinins, on lipid membranes. Biochim. Biophys. Acta 2006, 1758(9):1475-1482.
20. Vogel H.J., Schibli D.J., Jing W., Lohmeier-Vogel E.M., Epand R.F., et al. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem. Cell Biol 2002, 80:49-63.
21. Ramamoorthy A., Thennarasu S., Lee D.K., Tan A.M., Maloy L. Solid state NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from magainin 2 and mellitin. Biophys. J 2006, 91:206-216.
22. Epand R.F., Epand R.M., Formaggio F., Crisma M., Wu H.Y., et al. Analogs of the antimicrobial peptide trichogin having opposite membrane properties. Eur. J. Biochem 2001, 268:703-712.
23. Epand R.F., Epand R.M., Monaco V., Stoia S., Formaggio F., et al. The antimicrobial peptide trichogin and its interaction with phospholipid membranes. Eur. J. Biochem 1999, 55:358-363.
24. Powers J.P.S., Tan A., Ramamoorthy A., Hancock R.E.W. Solution structure and interaction of the antimicrobial polyphemusins with lipid membranes. Biochem 2005, 44:15504-15513.
25. Prenner E.J., Lewis R.N.A.H., McElhaney R.N. The interaction of the antimicrobial peptide gramicidin S with lipid bilayer model and biological membranes. Biochim. Biophys. Acta 1999, 1462:201-221.
26. Prenner E.J., Lewis R.N.A.H., Neuman K.C., Gruner S.M., Kondejewski L.H., et al. Nonlamellar phases induced by the interaction of gramicidin S with lipid bilayers. A possible relationship to membrane-disrupting activity. Biochemistry 1997, 36:7906-7916.
27. Hickel A., Danner-Pongratz S., Amenitsch H., Degovics G., Rappolt M., et al. Influence of antimicrobial peptides on the formation of nonlamellar lipid mesophases. Biochim. Biophys. Acta 2008, 1778:2325-2333.
28. Andrushchenko V.V., Vogel H.J., Prenner E.J. Interactions of tryptophan-rich cathelicidin antimicrobial peptides with model membranes studied by differential scanning calorimetry. Biochim. Biophys. Acta 2007, 1768:2447-2458.
29. Lohner K., Blondelle S.E. Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptides. Comb. Chem. High Throughput Screen 2005, 8:239-255.
30. Jing W., Prenner E.J., Vogel H.J., Waring A.J., Lehrer I.R. Headgroup structure and fatty acid chain length of the acidic phospholipids modulate the interaction of membrane mimetic vesicles with the antimicrobial peptide protegrin-1. J. Peptide Sci 2005, 11:735-743.
31. Abuja P.M., Zenz A., Trabi M., Craik D.J., Lohner K. The cyclic antimicrobial peptide RTD-1 induces stabilized lipid-peptide domains more efficiently than its open-chain analogue. FEBS Lett 2004, 566:301-306.
32. Adão R., Nazmi K., Bolscher J.G.M., Bastos M. C- and N-truncated antimicrobial peptides from LFampin 265-284: biophysical versus microbiology results. J. Pharm. Bio All. Sci 2011, 3(1):60-69.
33. Adão R., Seixas R., Gomes P., Costa Pessoa J., Bastos M. Membrane structure and interactions of a short lycotoxin I analogue. J. Peptide Sci 2008, 14:528-534.
34. Bolscher J.G., van der Kraan M.I., Nazmi K., Kalay H., Grün C.H., van't Hof W., et al. A one-enzyme strategy to release an antimicrobial peptide from the LFampin-domain of bovine lactoferrin. Peptides 2006, 27:1-9.
35. Aranda F.J., Teruel J.A., Ortiz A. Interaction of a synthetic peptide corresponding to the N-terminus of canine distemper virus fusion protein with phospholipid vesicles: a biophysical study. Biochim. Biophys. Acta 2003, 1618:51-58.
36. St Vincent M.R., Colpitts C.C., Ustinov A.V., Muqadas M., Joyce M.A., et al. Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses. Proc. Nat. Acad. Sci 2010, 107:17339-17344.
37. D'Souza C., Kanyalkar M., Joshi M., Coutinho E., Srivastava S. Search for novel neuroaminidase inhibitors: design, synthesis and interaction of oseltamivir derivatives with model membrane using docking, NMR and DSC methods. Biochim. Biophys. Acta 2009, 1788(9):1740-1751.
38. Pawar B., Joshi M., Srivastava S., Kanyalkar M. In search of a novel antifungal agent: probing molecular interactions of fluconazole and its analogues with model membranes by NMR and DSC techniques. J. Pharm. Pharmac 2012, 64(6):802-810.